Hallucinogenic drug use and depression, psychological distress and suicidality among disabled adults in the US.
Samantha M Ross-Cypcar, Justin A Haegele, Jeanette M Garcia
Addictive behaviors November 1, 2025 DOI: 10.1016/j.addbeh.2025.108454 via PubMed
Summary
Among disabled adults, past-year hallucinogen use is more common (8.37%) than among nondisabled adults (4.86%). Of disabled adults who used hallucinogens, nearly half reported a major depressive episode, over two-thirds reported serious psychological distress, and about 40% reported suicidal thinking, planning, or attempt. About 4% said hallucinogen use worsened or caused emotional or mental health problems. The findings come from a nationally representative sample of adults aged 18–50.
Study at a glance
| Characteristics | Cross-sectional analysis of nationally representative survey data Peer reviewed |
|---|---|
| Sample size | 107,781 |
| Population | U.S. adults ages 18–50, including disabled and nondisabled adults |
| Keywords | Ableism Illicit drugs Impairment People with disabilities |
| Key finding | Disabled adults who used hallucinogens in the past year had high rates of major depressive episodes, serious psychological distress, and suicidality, and hallucinogen use was more prevalent among disabled than nondisabled adults. |
Abstract
While recent nationally representative studies have evaluated the association between hallucinogen use and mental health events, little is known about these associations among disabled adults. Our primary aim was to use national data from the 2021, 2022, and 2023 National Survey on Drug Use and Health (NSDUH) to determine how past-year use of specific hallucinogens is associated with disabled adults reporting past-year SPD, MDE, and suicidality. A subsample of adults ages 18 to 50 years old (n = 107,781) was drawn from the 2021-2023 combined NSDUH dataset for this analysis. Descriptive analyzes generated weighted prevalence estimates for hallucinogen use and mental health outcomes, and crude odds ratios for experiencing a mental health outcome among past year hallucinogen users were estimated in comparison to non-hallucinogen users, stratified by disability status. The weighted prevalence of hallucinogen use in the past year was significantly higher among disabled (8.37 %) compared to nondisabled adults (4.86 %; p < 0.0001). Among disabled adults who used hallucinogens in the past year, 48.87 % reported a major depressive episode, 68.93 % reported a serious psychological distress indicator, and 39.65 % reported suicidal thinking, planning, or attempt. About 4 % of disabled adults reported that hallucinogen use in the past year worsened or caused emotional or mental health problems. Findings provide evidence of differences to the degree that disabled adults are using hallucinogens in comparison to nondisabled adults using a nationally representative sample. These findings provide new data to help understand hallucinogen use in relation to mental health events among this population.